News about Digitalization

Sophia Genetics Signs MoU with Memorial Sloan Kettering Cancer Center

Sophia Genetics has signed a strategic collaboration Memorandum of Understanding (MoU) with Memorial Sloan Kettering Cancer Center to establish a next-generation precision medicine hub.

Digitalization | 08/06/2026 | By News Bureau

Owkin and Sanofi Partner to Develop AI Agents for Drug Discovery

Owkin and Sanofi have expanded their multi-year K Pro collaboration to develop AI agents that enhance drug discovery and development. By integrating agentic AI systems into research workflows, the partnership aims to unlock the full value of data, improve decision-making, and accelerate the development of innovative therapies.

Digitalization | 06/06/2026 | By News Bureau

Sygnature Discovery Partners with DaltonTx to Advance AI-Driven Drug Discovery

Sygnature Discovery has partnered with DaltonTx to enhance Artificial Intelligence (AI)-enabled drug discovery capabilities, accelerating medicinal chemistry decision-making while maintaining robust data security standards to support faster and more efficient therapeutic research and development.

Digitalization | 05/06/2026 | By News Bureau |  103

HBSUK and Hexaware Partner to Digitise Healthcare Workforce Management

HBSUK and Hexaware Technologies launches digital workforce management solution to accelerate clinician onboarding, enhance compliance processes and support healthcare providers in addressing growing workforce and patient care demands.

Digitalization | 04/06/2026 | By News Bureau

Medidata Launches Next-Gen AI Imaging Solution for Faster Clinical Trials

Medidata unveiled next-generation AI-powered imaging capabilities within the Medidata Data Experience at ASCO 2026, enabling faster, more precise clinical trials.

Digitalization | 02/06/2026 | By News Bureau |  111

Tempus Launches Next-Generation Lens AI Platform for Oncology Drug Development

Tempus has unveiled the next-generation Lens platform, expanding its agentic AI capabilities for oncology drug development by leveraging over a decade of longitudinal real-world data and advanced analytics to generate actionable insights for biopharma research, clinical development, and precision medicine.

Digitalization | 01/06/2026 | By News Bureau |  167

Parexel Launches ParexelAI to Speed Up Clinical Development

Parexel launches ParexelAI, a proprietary Artificial Intelligence (AI) platform designed to accelerate clinical development by improving trial speed, efficiency, and data quality for sponsors and patients.

Digitalization | 20/05/2026 | By News Bureau |  134

Harbour BioMed Reports Promising Preclinical Data for AI-Driven Drug Candidate LET003

Harbour BioMed announced promising preclinical data for LET003, its first Artificial Intelligence (AI)-enabled drug candidate, highlighting potential as a next-generation obesity therapy targeting ACVR2A/2B.

Digitalization | 18/05/2026 | By News Bureau |  275

Tempus AI Expands Strategic Partnership with Bristol Myers Squibb

Tempus AI expands its collaboration with Bristol Myers Squibb to use Artificial Intelligence (AI) and real-world data for optimising oncology and neuroscience clinical trials and improving regulatory success rates.

Digitalization | 15/05/2026 | By News Bureau |  251

Insilico Medicine and Ribo Partner on AI-Powered RNA Therapeutics Development

Insilico Medicine and Ribo partner to accelerate RNA interference and oligonucleotide drug development using Artificial Intelligence (AI)I-powered discovery platforms and automated laboratory technologies.

Digitalization | 13/05/2026 | By News Bureau |  128